Makes laboratory equipment for pharmaceutical research and testing.
Jun 2026Revenue $87.8M/yrExpenses $88.1M/yr
No trendCash runway ≈ 5.8 years from Jun 2026
Figures by year
When will Harvard Bioscience be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $87.8M and expenses $88.1M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $86.5M | $135M | −$48.6M |
| Dec 2024 | $94.1M | $100M | −$6.21M |
| Dec 2023 | $112M | $110M | $1.89M |
| Dec 2022 | $113M | $120M | −$6.93M |
| Dec 2021 | $119M | $117M | $2.07M |
| Dec 2020 | $102M | $102M | $221K |
| Dec 2019 | $116M | $116M | $377K |
| Dec 2018 | $121M | $120M | $984K |
| Dec 2017 | $77.4M | $78.0M | −$635K |
| Dec 2016 | $105M | $108M | −$3.00M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.